Result is as expected and as telegraphed. However, a few surprises:
1) The reduction in NIM from 12% to 10%. Magnitude of the decline suggests more than just a 'pricing for risk' adjustments as a result of writing higher quality new business; 2) Commission expense up 134% to $4.4m on lower revenue and slightly higher originations. Appear to be paying more for their growth? This, together with the lower NIM suggests increasing competitive intensity; 3) Reduced funding facilities - always the achilles heal of all 2nd and 3rd tier lenders; 4) MME took a $6m ECL provision in 2H23 (management overlay) and there is no mention of it in this result => resulted in a 2H23 NPAT of $3m and 1H24 of $6m, which appears promising, but (and asking for confirmation here) suggests a LFL decline from $9m in 2H23 to $6m in 2H24 (33% down). Does anyone know if the $6m provision was used in the 1H24 result?
MME Price at posting:
8.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)